VBI Vaccines
VBIV
#10697
Rank
HK$14.67 M
Marketcap
HK$0.51
Share price
0.00%
Change (1 day)
-89.30%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -HK$79.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$79.45. In 2022 the company made an earnings per share (EPS) of -HK$103.43 a decrease over its 2021 EPS that were of -HK$63.47.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$79.49
2022-HK$103.4362.96%
2021-HK$63.4728.57%
2020-HK$49.36-54.35%
2019-HK$108.13-52.58%
2018-HK$228.0110.23%
2017-HK$206.8514.29%
2016-HK$181.00-62.8%
2015-HK$486.5890.68%
2014-HK$255.18-7.95%
2013-HK$277.24-57.97%
2012-HK$659.68-78%
2011-HK$2,9993151.47%
2010-HK$92.2423.87%
2009-HK$74.46-18.48%
2008-HK$91.3512.08%
2007-HK$81.51-49.47%
2006-HK$161.31
2005N/A-100%
2004-HK$71.7111.94%
2003-HK$64.06-81.89%
2002-HK$353.72196.44%
2001-HK$119.3284.33%
2000-HK$64.73-65.37%
1999-HK$186.93-29.45%
1998-HK$264.9529.61%
1997-HK$204.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.44-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-HK$28.76-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$33.93-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA